HEMATOLOGY

UCSD Murine Hematology and Coagulation Core Laboratory
Dr. Dzung T. Le, M.D., Ph.D., Director

To arrange for hematology, blood serum chemistry, and coagulation services, contact the lab via email to set an appointment and receive instructions for the shipping and handling of samples.

To schedule services: Qiongyu Chen at q2chen@ucsd.edu and Michelle Abueg at mabueg@ucsd.edu

Lab phone: (858) 534-3172

Service prices for UCSD investigators:

Service Price per sample Includes Sample
HEMATOLOGY $30 CBC, WBC differential, Platelet count; Smear for staining and viewing. Whole blood with EDTA anticoagulant
CHEMISTRY
- Comprehensive Metabolic Panel
$60 Albumin, ALP, ALT, AST, Anion Gap, Bicarbonate, BUN, Calcium, Creatinine, Chloride, Glucose, Potassium, Sodium, Total Bilirubin, and Total Protein Serum
- Lipid panel $60 Cholesterol, Triglycerides, HDL-cholesterol, LDL-cholesterol (calculated) Serum
COAGULATION
- PT
$60 Prothrombin time Citrated Plasma
- aPTT $60 Activated partial thromboplastin time Citrated Plasma
- Coagulation Factor: II, V,
VII, VIII, IX, X, XI, and XII
$60 Coagulation factor activity (each tested and priced individually) Citrated Plasma
- Fibrinogen $60 Fibrinogen activity Citrated Plasma
- Antithrombin $60 Antithrombin activity Citrated Plasma
- Protein C $60 Protein C activity Citrated Plasma
- Protein S $60 Protein S antigen concentration Citrated Plasma
- Plasminogen $60 Plasminogen activity Citrated Plasma
- Antiplasmin $60 Antiplasmin activity Citrated Plasma
- vWF $60 vWF antigen concentration Citrated Plasma

Hematology special consideration: This service is only available locally (San Diego County), as samples are only viable 4 hours after collection. Overnight shipping of samples will not be accepted.

Additional Services: Platelet aggregometry and additional serum chemistry analyses are also available. Inquire for prices and methods.

Processing Samples for Hematology (CBC)

  • Whole blood samples should be collected into tubes with an anticoagulant, preferably EDTA (lavender top).
  • Samples must be tested within 4 hours of collection to avoid coagulation and to ensure accurate results.
  • Analysis is done using a Hemavet 950FS Multi-Species Hematology System (Drew Scientific, CT) programmed with species-specific (e.g., mouse, monkey, dog, human) settings.
  • Background checks are run before sample analysis to verify that background counts are within acceptable limits.
  • A mouse control reference is supplied by the manufacturer and is tested each time samples are run for calibration control.
    • Control reference for other species are not kept in stock; contact our lab to discuss ordering.
  • All samples are tested in duplicate (unless otherwise specified) for a Complete Blood Count (CBC) with leukocyte differential, and a Platelet count.
  • Results may be given as individual sample report sheets and/or a cumulative excel file.
  • A whole blood smear is prepared for each sample and is available for reference upon request.

SERUM CHEMISTRY

Retro-Orbital Sinus Blood Collection (for Serum Chemistry)

  1. Mice are kept under general (inhalant) anesthesia
  2. The venous plexus of the orbit is accessible directly behind the eyeball
  3. The scruff of the animal is pulled back and the orbit is punctured behind the eyeball with a microhematocrit tube containing no additive
  4. Blood drops are collected into a Microtainer Serum Separator Tube (SST, P/N: 365957) with no anticoagulant
  5. Light pressure is applied to the area around the eye with a Kimwipe tissue to close the eye and stop the bleeding
  6. Mice are returned to their cage and observed during recovery

Cardiac Puncture Blood Collection (for Serum Chemistry)

Materials

  1. Inhalant anesthetic
  2. 1mL plastic syringe with a 25ga. needle
  3. Microtainer Serum Separator Tube(s) (SST, product number 365967)

Procedure

  1. Mice are kept under general (inhalant) anesthesia
  2. One of two methods may be used
    1. Open - body cavity is opened to expose the heart
    2. Closed - a needle is inserted through the intact skin, between the ribs, to reach the heart
  3. The needle is inserted to the heart and up to 1mL of blood is withdrawn
  4. Blood is emptied into a plastic mc tube
  5. Mice are euthanized by cervical dislocation

Processing Samples for Chemistry (Comprehensive Metabolic Panel, or Lipid Panel)
300ul of serum required for each panel (e.g., if both Metabolic & Lipid panel requested, 300ul + 300ul = 600ul required)

  1. Collected blood is allowed to clot over 4 hours at room temperature
  2. Blood is then spun in the SST for 5 minutes at 7000 rcf
  3. Serum supernatant is removed and placed into a 1.5ml mc tube

COAGULATION STUDIES

Cardiac Puncture Blood Collection (for Coagulation Studies - Citrated Plasma)

Materials

  1. Inhalant anesthetic
  2. 1mL plastic syringe with a 25ga. needle
  3. Buffered citrate (0.06 mole/L sodium citrate, 0.04 mole/L citric acid, pH 7.4)
  4. Microtubes

Procedure

  1. Mice are kept under general (inhalant) anesthesia
  2. One of two methods may be used
    1. Open - body cavity is opened to expose the heart
    2. Closed - a needle is inserted through the intact skin, between the ribs, to reach the heart
  3. The syringe is loaded with 30uL buffered citrate and capped with the needle
  4. The needle is inserted to the heart and up to 1mL of blood is withdrawn. Note the volume.
  5. Blood is emptied into a plastic mc tube containing sufficient additional citrate to achieve a final ratio of nine parts whole blood to one part citrate (9:1)
  6. Blood is immediately mixed well by tapping and inverting the tube five times to ensure proper anticoagulation. (if the sample is not mixed well, blood will clot and cannot be analyzed)
  7. Mice are euthanized by cervical dislocation
  8. Sample is centrifuged twice at 2000 rcf for 15 min at 22℃
  9. Plasma is drawn off the top and aliquoted and frozen at -80℃ within four hours of puncture

Materials for All Clotting Time Studies*

  1. ST4 semi-automated mechanical coagulation instrument (Diagnostica Stago, NJ)
  2. 4-well cuvettes
  3. Magnetic mixing balls
  4. Citrated plasma samples

Prothrombin Time (PT)

Measures the time to clot formation, indicating the activity of the extrinsic and common coagulation pathways and their involved clotting factors.

Additional Materials*

  1. Thromboplastin reagent

Procedure

  1. Instrument, cuvettes, mixing balls, and thromboplastin reagent are pre-warmed to 37℃
  2. 30uL of citrated plasma samples, in duplicate (2x), are incubated within cuvette wells at 37℃ for 3 minutes
  3. 60uL of thromboplastin reagent is added to each well to initiate clotting
  4. Time until clot formation is measured in seconds

Activated Partial Thromboplastin Time (aPTT)

Measures the time to clot formation, indicating the activity of the intrinsic and common coagulation pathways and their involved clotting factors.

Additional Materials*

  1. APTT reagent
  2. 25mM CaCl2

Procedure

  1. Instrument, cuvettes, mixing balls, and CaCl2 are pre-warmed to 37℃
  2. 30uL of citrated plasma samples, in duplicate (2x), are added to each well, followed by 30uL of aPTT reagent, and then incubated at 37℃ for 5 minutes
  3. 30uL of CaCl2 is added to each well to initiate clotting
  4. Time until clot formation is measured in seconds

Factor VIII

Key coagulation factor of the intrinsic pathway; activity levels are based on correction of clotting time for plasma deficient of the factor of interest and is reported as a percent.

Additional Materials*

  1. HN/BSA
  2. aPTT reagent
  3. 25mM CaCl2
  4. Citrated plasma deficient of factor VIII
  5. Normal mouse plasma (NMP) BL/6 pool

Procedure

  1. Instrument, cuvettes, and mixing balls are pre-warmed to 37℃
  2. Citrated plasma samples are diluted 1/20 in HN/BSA
  3. 30uL of sample dilutions, in duplicate, are added to each well, followed by 30uL of aPTT reagent, and then 30uL of citrated plasma deficient of factor VIII, and incubated at 37℃ for 5 minutes
  4. 30uL of CaCl2 is added to each well to initiate clotting
  5. Time until clot formation is measured
  6. Time is interpolated on a standard curve based on NMP serial dilutions and reported as %BL/6

Factor IX, Factor XI, and Factor XII

Follow the factor VIII method, using plasma deficient of the specific factor being measured in place of factor VIII deficient plasma.

Factor VII

Key coagulation factor of the extrinsic and common pathway; activity levels are based on correction of clotting time for plasma deficient of the factor of interest and is reported as a percent.

Additional Materials*

  1. Owren's Veronal Buffer
  2. Thromboplastin reagent
  3. Citrated plasma deficient of factor VII
  4. Normal mouse plasma (NMP) BL/6 pool

Procedure

  1. Instrument, cuvettes, and mixing balls are pre-warmed to 37℃
  2. Citrated plasma samples are diluted 1/200 in Owren's Veronal Buffer
  3. 30uL of sample dilutions, in duplicate, are added to each well, and then 30uL of citrated plasma deficient of factor VII§ , and incubated at 37℃ for 3 minutes
  4. 60uL of thromboplastin reagent is added to each well to initiate clotting
  5. Time until clot formation is measured
  6. Time is interpolated on a standard curve based on NMP serial dilutions and reported as %BL/6

Factor II, Factor V, and Factor X

Follow factor VII method, using plasma deficient of the specific factor being measured in place of factor VII§ deficient plasma.

Fibrinogen Activity Assay

Activity of fibrinogen, activated by thrombin, is measured in time to clot formation.

Additional Materials*

  1. Owren's Veronal Buffer
  2. Bovine thrombin reagent

Procedure

  1. Citrated plasma samples are diluted 1:15 in Owren's Veronal Buffer
  2. 45uL of sample dilutions, in duplicate, are incubated at 37℃ for 3min
  3. A log-log standard curve is prepared by diluting NMP 1:5 to 1:40 in Owren's Veronal Buffer
  4. 22.5uL of bovine thrombin reagent are added to activate fibrin clot formation
  5. Measured clotting times are converted to fibrinogen concentration using the standard curve

Materials for all Immunologic and Chromogenic Assays†

  1. Versa Max microtiter plate reader (Molecular Devices, CA)
  2. 96-well microtiter plate
  3. Citrated plasma samples
  4. Normal mouse plasma (NMP)

AntiThrombin Assay

Antithrombin activity is measured by level of inhibition of Factor Xa.

Additional Materials✝

  1. HN/BSA
  2. Factor Xa/Heparin reagent
  3. 1.25 mg/ml chromogenic substrate S-2765

Procedure

  1. Plasma samples are diluted to 1:40 and 1:80 in HN/BSA
  2. Plate wells are loaded as follows:
    Sample dilutions, in duplicate 40uL 37℃ 3min
    Factor Xa/Heparin reagent 40uL
    Chromogenic substrate 40uL Color development
  3. Plate is read at 405nm
  4. Standard curve is prepared with each plate by diluting NMP 1:20 to 1:640 in HN/BSA, analyzed simultaneously on the sample plate

Protein C Assay

Activity is measured by the level of chromogenic substrate cleaved by activated protein C.

Additional Materials✝

  1. TBS with 100mM CsCl
  2. 2 u/mL Protein C activator
  3. 2.5mM chromogenic substrate specific for activated Protein C (APC)
  4. 20% acetic acid

Procedure

  1. Plasma samples are diluted to 1:10 in TBS/CsCl
  2. Plate wells are loaded as follows:
    Sample dilutions, in duplicate 10uL 37℃ 15min
    Protein C activator 25uL 37℃ 15min
    Chromogenic substrate 25uL 37℃ 1hr Color development; plate must be covered
    Acetic acid 25uL 37℃ 1hr Stop reaction
  3. Plate is read at 405nm
  4. Standard curve is prepared by diluting NMP 1:4 to 1:64 in TBS, analyzed simultaneously on the sample plate
  5. Absorbance are converted to %NMP protein C using the standard curve

Protein S Assay

Concentration of protein S antigen is determined by binding to an antibody, then secondary binding by a conjugated antibody that will produce a detectable color change with the addition of a substrate.

Additional Materials✝

  1. 10 ug/uL rabbit anti-human protein S polyclonal antibody prepared in 50mM Na2CO3, pH 9.6
  2. TBS
  3. 3% BSA in TBS
  4. 1% BSA in TBS
  5. 0.05% Tween 20 in TBS
  6. Horseradish peroxidase (HRP)-conjugated rabbit anti-human Protein S polyclonal antibodies diluted 1/1000 in 1%BSA in TBS
  7. TMB peroxidase substrate
  8. 1N H2SO4

Procedure

  1. Plasma samples are diluted to 1:100 in TBS/1%BSA
  2. Plate wells are loaded as follows:
    Rabbit anti-human protein S Ab 100uL 5℃ Overnight
    3%BSA in TBS 200uL 37℃ or 5℃ 3-5hr or Overnight Block
    1%BSA in TBS Wash 1x
    Sample dilutions, in duplicate 100uL 5℃ Overnight
    0.05% Tween 20 in TBS Wash 5x
    Diluted HRP-conjugated rabbit Ab in TBS/1%BSA 100uL 5℃ Overnight
    0.05% Tween 20 in TBS Wash 5x
    TMB peroxidase substrate 4hr Color development
    H2SO4 100uL Stop reaction
  3. Plate is read at 450nm
  4. Log-log standard curve is prepared by diluting NMP 1:25 to 1:800 in TBS/1%BSA, analyzed simultaneously on the sample plate
  5. Absorbance are converted to %NMP Protein S using the standard curve

Plasminogen Activity Assay

Activity is measured by the level of chromogenic substrate cleaved by plasmin, activated by urokinase.

Additional Materials✝

  1. 100mM Tris, pH 8.5 with 8.3mM EACA (Tris/EACA)
  2. 2500 Ploug U/mL urokinase
  3. 1.2mM chromogenic substrate specific for plasmin and urokinase-activated plasminogen in HN buffer
  4. 20% acetic acid

Procedure

  1. Plasma samples are diluted to 1:50 in Tris/EACA
  2. Plate wells are loaded as follows:
    Sample dilutions, in duplicate 60uL 37℃ 90sec
    Urokinase 20uL 60sec
    Chromogenic substrate in HN 100uL 10min Color development
    Acetic acid 100uL Stop reaction
  3. 100uL of is added to each well for color development
  4. Plate is read at 405nm
  5. Log-log standard curve is prepared by diluting normal mouse plasma (NMP) 1:10 to 1:320 in Tris/EACA, analyzed simultaneously on the sample plate
  6. Absorbance are converted to %NMP plasminogen using the standard curve

Alpha-2 AntiPlasmin Assay

Antiplasmin activity is measured by level of inhibition of plasmin.

Additional Materials✝

  1. TBS with 120mM methylamine
  2. 10ug/mL plasmin
  3. 3mM chromogenic substrate specific for plasmin
  4. 20% acetic acid

Procedure

  1. Plasma samples are diluted to 1:50 in TBS with methylamine
  2. Plate wells are loaded as follows:
    Sample dilutions, in duplicate 50uL 37℃ 10min
    Plasmin 50uL 90sec
    Chromogenic substrate 50uL 10min Color development
    Acetic acid 50uL Stop reaction
  3. Plate is read at 405nm
  4. Standard curve is prepared by diluting NMP 1:10 to 1:640 in TBS with methylamine, analyzed simultaneously on the sample plate
  5. Absorbance are converted to %NMP alpha-2 antiplasmin using the standard curve

vonWillebrand Factor (vWF) Antigen Assay

Concentration of vonWillebrand Factor antigen is determined by binding to an antibody, then secondary binding by a conjugated antibody that will produce a detectable color change with the addition of a substrate.

Additional Materials✝

  1. 10ug/ml rabbit anti-human vWF polyclonal antibody prepared in 50mM Na2CO3, pH 9.6
  2. 3% BSA in TBS
  3. 1% BSA in TBS
  4. 0.05% Tween 20 in TBS
  5. Horseradish peroxidase(HRP)-conjugated rabbit anti-human vWF polyclonal antibodies diluted 1/2000 in 1% BSA in TBS
  6. TMB peroxidase substrate

Procedure

  1. Plasma samples are diluted to 1:200 in TBS/1%BSA
  2. Plate wells are loaded as follows:
    Block 100uL Rabbit anti-human vWF Ab 5℃ Overnight
    Block 200uL 3% BSA in TBS 5℃ or 37℃ Overnight Or 3-5hr
    100uL Sample dilutions, in duplicate 5℃ Overnight
    Wash 5x TBS/Tween
    100uL HRP-conjugated rabbit anti-human vWF Ab 5℃ Overnight
    Wash 5x TBS/Tween
    Color development TMB peroxidase substrate
  3. Plate is read at 655nm
  4. Log-log standard curve is prepared by diluting NMP 1:25 to 1:160 in 1% BSA in TBS, analyzed simultaneously on the sample plate
  5. Absorbance are converted to %NMP vWF using the standard curve

An official web page of the University of California, San Diego